Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, December 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Easily Determine Trace Morpholine and More in Linezolid
Tuesday, November 26, 2013
Determination of morpholine in linezolid by ion chromatography method.

Huber RotaCool® Chiller Now Reduced in Price
Friday, November 15, 2013
Highest cooling capacity at minimal bench space - now for 20 percent less!

Rapidly Explore Available Chemistry Space in Spark V10.2
Friday, November 15, 2013
Powerful tool for finding biologically equivalent replacements for key moieties in users molecule.

Agilent Introduces New ProPulse NMR Platform
Tuesday, November 12, 2013
Compact system provides simple, walk-up performance for applied chemistry research, drug discovery, food science and metabolomics.

Video Introduction to CHN Microanalysis Technique
Friday, November 08, 2013
Precise determination of percentage Carbon, Hydrogen and Nitrogen in a sample.

NETZSCH Unveils the New Paradigm in Differential Scanning Calorimetry
Thursday, November 07, 2013
For the first time, each of the steps involved in running a Differential Scanning Calorimetry (DSC) measurement has been taken into account in developing a comprehensive new solution.

Avoiding Sample Loss During Evaporative Drying
Tuesday, November 05, 2013
Dri-Pure® technology from Genevac offers significant benefits to scientists, especially those working in synthesis and purification.

Protocol for Preparing Top Quality Lyophilised Samples
Tuesday, November 05, 2013
Genevac Develops protocol for improving evaporation and lyophilisation results.

Are You Really Speaking the Same Language As Your Customers?
Monday, November 04, 2013
Swift Analytical announces a multi-lingual translation service for all your marketing needs and PR needs.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 1279
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn